<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mild <z:hpo ids='HP_0002045'>hypothermia</z:hpo> is neuroprotective, but the reasons are not well known </plain></SENT>
<SENT sid="1" pm="."><plain><z:mp ids='MP_0001845'>Inflammation</z:mp> contributes to ischemic damage; therefore, we examined whether the protection by <z:hpo ids='HP_0002045'>hypothermia</z:hpo> may be attributable to alterations in the <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>We examined whether <z:hpo ids='HP_0002045'>hypothermia</z:hpo> might alter the inflammatory cell-associated inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (iNOS) and subsequent nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) and <z:chebi fb="0" ids="25941">peroxynitrite</z:chebi> generation in experimental <z:hpo ids='HP_0001297'>stroke</z:hpo> and <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Rats underwent 2 hr of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0001847'>Brain inflammation</z:mp> was modeled by intravenous <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi> (LPS) (2 mg/kg) injection </plain></SENT>
<SENT sid="5" pm="."><plain>Temperature was maintained at 33 degrees C for 2 hr immediately after MCAO and LPS injection, delayed 2 hr after MCAO or maintained at 38 degrees C </plain></SENT>
<SENT sid="6" pm="."><plain>Cultured microglia were activated with LPS and then incubated at 33 or 37 degrees C </plain></SENT>
<SENT sid="7" pm="."><plain>Both intraischemic and delayed mild <z:hpo ids='HP_0002045'>hypothermia</z:hpo> attenuated <z:mpath ids='MPATH_124'>infarct</z:mpath> size by 40% (p &lt; 0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>Immunohistochemistry was performed to identify cell type, iNOS, and <z:chebi fb="0" ids="25941">peroxynitrite</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>The majority of iNOS- and <z:chebi fb="0" ids="25941">peroxynitrite</z:chebi>-positive cells were activated microglia-macrophages, and mild <z:hpo ids='HP_0002045'>hypothermia</z:hpo> significantly decreased the numbers of immunoreactive cells at 72 hr by &gt;50% (p &lt; 0.05) </plain></SENT>
<SENT sid="10" pm="."><plain>After <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, mild <z:hpo ids='HP_0002045'>hypothermia</z:hpo> decreased NO production by 40% </plain></SENT>
<SENT sid="11" pm="."><plain>Similarly, <z:hpo ids='HP_0002045'>hypothermia</z:hpo> attenuated NO and iNOS in LPS-injected rats, as well as in cultured microglia </plain></SENT>
<SENT sid="12" pm="."><plain><z:chebi fb="0" ids="40618">Aminoguanidine</z:chebi>, an iNOS inhibitor, also attenuated <z:mpath ids='MPATH_124'>infarct</z:mpath> size and NO in ischemic and <z:mp ids='MP_0001845'>inflammation</z:mp> models </plain></SENT>
<SENT sid="13" pm="."><plain>We conclude that mild <z:hpo ids='HP_0002045'>hypothermia</z:hpo> significantly inhibits the <z:mp ids='MP_0001845'>inflammatory response</z:mp> by affecting microglial iNOS-NO generation </plain></SENT>
<SENT sid="14" pm="."><plain>Therapies directed against microglia or their activation may be useful in treating <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>